I agree that this site is using cookies. You can find further informations here.
X
Poondru, Srinivasu
34  results:
Search for persons X
?
1

Clinical Pharmacology of the Antibody–Drug Conjugate Enfort..:

Tang, Mei ; Garg, Amit ; Bonate, Peter L....
Clinical Pharmacokinetics.  63 (2024)  4 - p. 423-438 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Dose Optimization in Oncology Drug Development: An Internat..:

Samineni, Divya ; Venkatakrishnan, Karthik ; Othman, Ahmed A....
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Enzalutamide: Understanding and Managing Drug Interactions ..:

Lennep, Brandon W. ; Mack, Jesse ; Poondru, Srinivasu...
Drug Safety.  47 (2024)  7 - p. 617-641 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Physiologically-based pharmacokinetic modeling to predict d..:

Otsuka, Yukio ; Poondru, Srinivasu ; Bonate, Peter L....
Journal of Pharmacokinetics and Pharmacodynamics.  50 (2023)  5 - p. 365-376 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Effect of enzalutamide on PK of P‐gp and BCRP substrates in..:

Poondru, Srinivasu ; Ghicavii, Vitalii ; Khosravan, Reza...
Clinical and Translational Science.  15 (2022)  5 - p. 1131-1142 , 2022
Link: https://doi.org/10.1111/..
 
?
6

A Randomized Phase II Study of AGS-16C3F Versus Axitinib in..:

Kollmannsberger, Christian ; Choueiri, Toni K. ; Heng, Daniel Y.C....
The Oncologist.  26 (2021)  3 - p. 182-e361 , 2021
Link: https://doi.org/10.1002/..
 
?
7

Phase 2 study evaluating intermittent and continuous linsit..:

Oza, Amit ; Kaye, Stanley ; Van Tornout, Jan...
Gynecologic Oncology.  149 (2018)  2 - p. 275-282 , 2018
Link: https://doi.org/10.1016/..
 
?
8

P2.06-021 Efficacy and Safety of ASP8273 versus Erlotinib o..:

Kelly, Ronan ; Horn, Leora ; Chih-Hsin Yang, James...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1083-S1084 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Phase 2 Study of Erlotinib in Combination With Linsitinib (..:

Leighl, Natasha B. ; Rizvi, Naiyer A. ; de Lima Jr., Lopes Gilberto...
Clinical Lung Cancer.  18 (2017)  1 - p. 34-42.e2 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Randomised Phase 2 study of maintenance linsitinib (OSI-906..:

Ciuleanu, Tudor-Eliade ; Ahmed, Samreen ; Kim, Joo-Hang...
British Journal of Cancer.  117 (2017)  6 - p. 757-766 , 2017
Link: https://doi.org/10.1038/..
 
?
11

A first in man, dose-finding study of the mTORC1/mTORC2 inh..:

Mateo, Joaquin ; Olmos, David ; Dumez, Herlinde...
British Journal of Cancer.  114 (2016)  8 - p. 889-896 , 2016
Link: https://doi.org/10.1038/..
 
?
12

Mass balance, pharmacokinetics, and metabolism of linsitini..:

Poondru, Srinivasu ; Chaves, Jorge ; Yuen, Geoffrey...
Cancer Chemotherapy and Pharmacology.  77 (2016)  4 - p. 829-837 , 2016
Link: https://doi.org/10.1007/..
 
?
13

Chronopharmacokinetics of Sumatriptan in Healthy Human Subj..:

Poondru, Srinivasu ; Devaraj, Rambhau ; Boinpally, Ramesh R.
Journal of Pharmacy and Pharmacology.  52 (2010)  9 - p. 1085-1090 , 2010
Link: https://doi.org/10.1211/..
 
?
14

Structure-Guided Design of Potent and Selective Pyrimidylpy..:

Aronov, Alex M. ; Tang, Qing ; Martinez-Botella, Gabriel...
Journal of Medicinal Chemistry.  52 (2009)  20 - p. 6362-6368 , 2009
Link: https://doi.org/10.1021/..
 
?
15

Identification of 3-amido-4-anilinoquinolines as potent and..:

Scott, David A. ; Balliet, Carrie L. ; Cook, Donald J....
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  3 - p. 697-700 , 2009
Link: https://doi.org/10.1016/..
 
1-15